Company profile · Biotech & medical
訊聯生物科技股份有限公司 · 1784
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Bionet provides cell therapy, storage and diverse application services, prenatal testing, exosome preparation, and contract manufacturing.[1]
The company's main business segments consist of cell storage and application services, prenatal testing, exosome preparation, and contract manufacturing, with cell storage services and applications serving as a key revenue source.[2]
Bionet is based in Taipei City, Taiwan.[1]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$94m | -12.0% | -2.7% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$9m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | BIONET CORP. |
|---|---|
| Chinese name | 訊聯生物科技股份有限公司 |
| Stock code | 1784 (TPEx) |
| Industry | Biotech & medical |
| Founded | 17 Aug 2000 |
| Listed | 26 Jul 2007 |
| Paid-in capital | NT$531m |
| Chairman | 蔡政憲 |
| President | 康清原 |
| Headquarters | 1F,No.28, Ln. 36 , Xinhu 1st Rd. Neihu Dist.,Taipei City 11497, , Taiwan |
| Website | http://www.BionetCorp.com |
| Official business description | 細胞治療 · 再生醫療 · 醫療大數據 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.